Join our Facebook group
Scholar Rock is a clinical-stage biopharmaceutical company.
51 - 200
💰 $205M Post-IPO Equity on 2022-06
August 8
Lead sales strategy and team for innovative SMA treatment launch.
🇺🇸 United States – Remote
⏰ Full Time
🔴 Lead
🤑 Sales
June 21
🟠 Senior
🚔 Compliance